Yasumasa Kuroda Selected Research

Alprostadil (Muse)

1/2022	Effects of human Muse cells on bladder inflammation, overactivity, and nociception in a chemically induced Hunner-type interstitial cystitis-like rat model.
1/2018	S1P-S1PR2 Axis Mediates Homing of Muse Cells Into Damaged Heart for Long-Lasting Tissue Repair and Functional Recovery After Acute Myocardial Infarction.
10/2017	Beneficial Effects of Systemically Administered Human Muse Cells in Adriamycin Nephropathy.
1/2016	Transplantation of Unique Subpopulation of Fibroblasts, Muse Cells, Ameliorates Experimental Stroke Possibly via Robust Neuronal Differentiation.
1/2015	Therapeutic effects of human multilineage-differentiating stress enduring (MUSE) cell transplantation into infarct brain of mice.
4/2014	Human adipose tissue possesses a unique population of pluripotent stem cells with nontumorigenic and low telomerase activities: potential implications in regenerative medicine.
10/2013	Functional melanocytes are readily reprogrammable from multilineage-differentiating stress-enduring (muse) cells, distinct stem cells in human fibroblasts.
1/2013	Isolation, culture and evaluation of multilineage-differentiating stress-enduring (Muse) cells.
1/2012	Isolation of adult human pluripotent stem cells from mesenchymal cell populations and their application to liver damages.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasumasa Kuroda Research Topics

Disease

2	Infarction (Infarctions) 01/2016 - 01/2015
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2016 - 01/2015
2	Teratoma (Teratoid Tumor) 04/2014 - 01/2013
1	Cystitis 01/2022
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Myocardial Infarction 01/2018
1	Fibrosis (Cirrhosis) 10/2017
1	Sclerosis 10/2017
1	Stroke (Strokes) 01/2016
1	Brain Infarction 01/2015
1	Ischemic Stroke 01/2015
1	Teratogenesis 04/2014
1	Vitiligo 10/2013
1	Parkinson Disease (Parkinson's Disease) 01/2013
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2013
1	Liver Diseases (Liver Disease) 01/2012
1	Lung Neoplasms (Lung Cancer) 02/2002
1	Radiation Pneumonitis 02/2002
1	Esophagitis 02/2002
1	Spinal Cord Diseases 02/2002

Drug/Important Bio-Agent (IBA)

9	Alprostadil (Muse)FDA LinkGeneric 01/2022 - 01/2012
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022
1	CreatinineIBA 10/2017
1	NPHS2 proteinIBA 10/2017
1	stage-specific embryonic antigen-3 (GL-X)IBA 01/2016
1	Biological ProductsIBA 01/2016
1	Therapeutic UsesIBA 01/2015
1	Telomerase (Telomerase Reverse Transcriptase)IBA 04/2014

Therapy/Procedure

5	Transplantation 01/2016 - 01/2012
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2016 - 01/2013
2	Therapeutics 04/2014 - 01/2013
1	Intravesical Administration 01/2022
1	Cell Transplantation 01/2015
1	Autologous Transplantation 10/2013
1	Radiotherapy 02/2002
1	Re-Irradiation 02/2002